InvestmentPitch Media Video Discusses Rakovina Therapeutics' Receipt of Notice of Allowance for New U.S. Patent Covering kt-2000 Series PARP Inhibitors
- Written by Newsfile
Vancouver, British Columbia--(Newsfile Corp. - October 8, 2021) - Rakovina Therapeutics Inc. (TSXV: RKV) has received notice of allowance from the Untied States Patent and Trademark Office (USPTO) for a patent entitled "Tricyclic Inhibitors of Poly(ADP-Ribose) Polymerase."
For more information, please view the InvestmentPitch Media "video"...